Article

Pseudophakic IOL power calculation still a significant challenge in postrefractive surgery

A study evaluating different methods of calculating effective corneal power in eyes with a history of corneal refractive surgery reinforce there is no ideal means to measure that value, said Helga P. Sandoval, MD, Storm Eye Institute, Medical University of South Carolina, Charleston.

A study evaluating different methods of calculating effective corneal power in eyes with a history of corneal refractive surgery reinforce there is no ideal means to measure that value, said Helga P. Sandoval, MD, Storm Eye Institute, Medical University of South Carolina, Charleston.

"Therefore, it is important to discuss with patients preoperatively that there is an increased likelihood of needing IOL surgery exchange, piggybacking, or additional corneal surgery after the cataract procedure," Dr. Sandoval said.

Dr. Sandoval presented findings from four groups of eyes in which six different methods for calculating the effective corneal power after corneal refractive surgery were investigated. The target refractions based on actual and refraction-derived keratometric values were compared with the postoperative achieved refractions.

The four groups consisted of eyes that had undergone myopic LASIK (26 eyes), hyperopic LASIK (18 eyes), myopic PRK (4 eyes), or RK (5 eyes). In the two largest groups, the methods evaluated included the clinical history method, adjusted effective refractive power, Modified Maloney, Hill, Masket, and an eye scanner (Pentacam, Oculus).

In the myopic LASIK eyes, the effective refractive power, Masket, and Hill methods gave the most accurate results with respect to proportion of eyes within 1 D of target refraction. Using a cutoff of achieved refraction within 0.5 D of target, the Masket method performed best. For the hyperopic LASIK eyes, the Hill, Masket, effective refractive power, and historical data methods were all associated with high percentages of eyes within 1 D. For the analysis of achieved refraction within 0.5 D of target, the Hill and effective refractive power methods had the greatest accuracy.

"However, compared with eyes that have undergone myopic LASIK, determination of effective corneal power is less of a problem after hyperopic LASIK," Dr. Sandoval said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.